RhumbLine Advisers’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $275K | Sell |
|
|||||
|
2025
Q2 | $309K | Buy |
|
|||||
|
2025
Q1 | $174K | Sell |
|
|||||
|
2024
Q4 | $414K | Buy |
|
|||||
|
2024
Q3 | $122K | Sell |
|
|||||
|
2024
Q2 | $138K | Buy |
|
|||||
|
2024
Q1 | $8.08K | Hold |
|
|||||
|
2023
Q4 | $9.41K | Hold |
|
|||||
|
2023
Q3 | $11.5K | Sell |
|
|||||
|
2023
Q2 | $30.5K | Sell |
|
|||||
|
2023
Q1 | $158K | Buy |
|
|||||
|
2022
Q4 | $268K | Buy |
|
|||||
|
2022
Q3 | $362K | Buy |
|
|||||
|
2022
Q2 | $378K | Buy |
|
|||||
|
2022
Q1 | $422K | Sell |
|
|||||
|
2021
Q4 | $439K | Sell |
|
|||||
|
2021
Q3 | $365K | Buy |
|
|||||
|
2021
Q2 | $437K | Sell |
|
|||||
|
2021
Q1 | $486K | Sell |
|
|||||
|
2020
Q4 | $499K | Buy |
|
|||||
|
2020
Q3 | $394K | Sell |
|
|||||
|
2020
Q2 | $372K | Buy |
|
|||||
|
2020
Q1 | $375K | Buy |
|
|||||
|
2019
Q4 | $469K | Buy |
|
|||||
|
2019
Q3 | $450K | Buy |
|
|||||
|
2019
Q2 | $358K | Sell |
|
|||||
|
2019
Q1 | $483K | Buy |
|
|||||
|
2018
Q4 | $455K | Buy |
|
|||||
|
2018
Q3 | $383K | Hold |
|
|||||
|
2018
Q2 | $397K | Buy |
|
|||||
|
2018
Q1 | $334K | Sell |
|
|||||
|
2017
Q4 | $338K | Sell |
|
|||||
|
2017
Q3 | $410K | Buy |
|
|||||
|
2017
Q2 | $466K | Sell |
|
|||||
|
2017
Q1 | $463K | Buy |
|
|||||
|
2016
Q4 | $455K | Sell |
|
|||||
|
2016
Q3 | $485K | Buy |
|
|||||
|
2016
Q2 | $387K | Sell |
|
|||||
|
2016
Q1 | $440K | Buy |
|
|||||
|
2015
Q4 | $457K | Buy |
|
|||||
|
2015
Q3 | $419K | Buy |
|
|||||
|
2015
Q2 | $492K | Sell |
|
|||||
|
2015
Q1 | $538K | Buy |
|
|||||
|
2014
Q4 | $505K | Buy |
|
|||||
|
2014
Q3 | $409K | Hold |
|
|||||
|
2014
Q2 | $417K | Buy |
|
|||||
|
2014
Q1 | $266K | Sell |
|
|||||
|
2013
Q4 | $303K | Hold |
|
|||||
|
2013
Q3 | $305K | Buy |
|
|||||
|
2013
Q2 | $330K | Buy |
|